| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/09/1993 | CA2134338A1 Azavesamicols |
| 12/09/1993 | CA2118522A1 Time dependent administration of oligosaccharides glycosides related to blood group determinants having a type i or type ii core structure in reducing inflammation in a sensitizedmammal arising from exposure to an antigen |
| 12/09/1993 | CA2114623A1 Sulphamide derivatives as metalloproteinase inhibitors |
| 12/09/1993 | CA2114622A1 Peptidyl derivatives and their use as metalloproteinases inhibitors |
| 12/09/1993 | CA2114132A1 New fluorinated quinolones, process for their preparation and pharmaceutical compositions containing them |
| 12/09/1993 | CA2113809A1 Pharmaceutical composition for the treatment of acne vulgaris |
| 12/09/1993 | CA2070724A1 Composite anesthetic article and method of use |
| 12/08/1993 | EP0573392A1 Thiosemicarbazones derivatives and their use as pharmaceuticals |
| 12/08/1993 | EP0573391A1 Thiosemicarbazonic acid esters and their use as pharmaceuticals |
| 12/08/1993 | EP0573360A1 Pyrrolothienopyrazine compounds as 5-HT3 receptors antagonists |
| 12/08/1993 | EP0573318A1 Phenyl carboxamide isoxazole derivatives and salts, process for their preparation and the new intermediates thereof. Their use as pharmaceuticals and pharmaceutical compositions containing them |
| 12/08/1993 | EP0573271A1 Angiotensin II antagonists |
| 12/08/1993 | EP0573260A1 New alkaloid derivatives, their use and pharmaceutical formulations containing them |
| 12/08/1993 | EP0573253A2 Topical anti-bacterial composition |
| 12/08/1993 | EP0573221A1 The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy |
| 12/08/1993 | EP0573218A2 4-Carboxyimidazoles as angiotensin II antagonists and their thrapeutic use |
| 12/08/1993 | EP0573133A1 Means for transdermal application of Gestoden |
| 12/08/1993 | EP0572963A2 High efficacy sclerosing solution causing no iatrogenic lesions and process to obtain this solution |
| 12/08/1993 | EP0572952A1 4-Benzylpiperidine derivatives, a process for preparing them and pharmaceutical compositions containing them |
| 12/08/1993 | EP0572922A1 Synergistic combinations comprising lipoic acid and vitamines in medicaments |
| 12/08/1993 | EP0572909A1 Amino acid derivatives as renin inhibitors |
| 12/08/1993 | EP0572863A1 CNS pyrazinoindoles |
| 12/08/1993 | EP0572852A1 Quinoxalin-2,3(1H,4H)-diones used as medicine |
| 12/08/1993 | EP0572731A1 Chewable preparation containing a decongestant |
| 12/08/1993 | EP0572644A1 DERIVATIVES OF 9-($g(b)-D-XYLOFURANNOSYL)ADENINE AND OF 1-($g(b)-D-XYLOFURANNOSYL)CYTOSINE, PREPARATION THEREOF AND APPLICATION IN THERAPEUTICS |
| 12/08/1993 | EP0572635A1 Novel compounds having a guanidine structure and pharmaceutical composition containing same. |
| 12/08/1993 | EP0572627A1 Solvent system to be enclosed in capsules. |
| 12/08/1993 | EP0572615A1 Medicament for treatment of protozoal infections |
| 12/08/1993 | EP0572563A1 Treatment of esophageal cancer |
| 12/08/1993 | EP0572560A1 Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology |
| 12/08/1993 | EP0572557A1 Treatment of ovarian cancer |
| 12/08/1993 | EP0572549A1 Treatment of non-small cell lung carcinoma |
| 12/08/1993 | EP0572547A1 SUBSTITUTED $g(a)-AMINOALDEHYDES AND DERIVATIVES |
| 12/08/1993 | EP0572542A1 Method of treating systemic lupus erythematosus |
| 12/08/1993 | EP0572537A1 Cytokine inhibitors |
| 12/08/1993 | EP0572494A1 Composition for use in transdermal administration |
| 12/08/1993 | EP0572486A1 Delayed release oral dosage forms for treatment of intestinal disorders. |
| 12/08/1993 | EP0572455A1 Substituted pyridinones and pyrimidinones as angiotensin ii antagonists |
| 12/08/1993 | EP0572454A1 3-desmethylrapamycin or derivatives thereof, processes for their preparation and their use as antifungal agents and immunosuppressants |
| 12/08/1993 | EP0572451A1 Novel steroid esters |
| 12/08/1993 | EP0572449A1 (amidomethyl)nitrogen heterocyclic analgesics |
| 12/08/1993 | EP0572418A1 Novel gamma-pyrones, gamma-pyridones and gamma-thiopyrones and their use as medicaments and method for producing them |
| 12/08/1993 | EP0490920B1 Pharmaceutical preparation binding with gastric acid |
| 12/08/1993 | EP0480983B1 Use of peroxidated lipids for the preparation of medication to be used in the treatment, by local application, of circulation deficiencies |
| 12/08/1993 | EP0461218B1 Oxypurinol salt composition for oral administration for treating hyperurecemia |
| 12/08/1993 | EP0368994B1 Benzothiazepines for the preparation of medicaments for the amelioration of epileptic seizures |
| 12/08/1993 | EP0259496B1 Derivatives of cervinomycin antibiotics and process for their preparation |
| 12/08/1993 | CN1079256A Process for preparing antibiotic "Zhijiangjunsu" and its medicine for preventing and curing diseases of animals and fowls |
| 12/08/1993 | CN1079224A Antibiotic compounds |
| 12/08/1993 | CN1079223A Benzofuran derivatives |
| 12/08/1993 | CN1079219A Arylacetamides |
| 12/08/1993 | CN1079216A Chemical compounds |
| 12/08/1993 | CN1079215A Morpholinyl derivatives of doxorubicin and process for their preparation |
| 12/08/1993 | CN1079147A Urapidil slow-release preparation |
| 12/08/1993 | CN1079146A Drug material suitable for micronisation |
| 12/08/1993 | CN1079145A Usage of 3,4-oil hydroxy benzaldehyde |
| 12/08/1993 | CN1023017C Process for preparing macrolide compositions |
| 12/08/1993 | CN1023016C Process for preparing diastereomeric 5R, 6S-6-(1R-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids |
| 12/08/1993 | CN1023014C Process for preparing ergoline derivatives |
| 12/08/1993 | CN1023013C Process for preparing thianaphthene derivatives |
| 12/08/1993 | CN1023010C Process for preparing 4-heteropentacyctic-4-(N-(phenyl) amido) piperidine derivatives |
| 12/08/1993 | CN1023009C Process for preparation of optically pure compound |
| 12/08/1993 | CN1023007C Process for preparing pyrrolidine derivatives |
| 12/08/1993 | CN1022973C Method and apparatus for preparing food foodstuffs |
| 12/07/1993 | US5268482 Containing piperidine ring substituted with ether or sulfide groups |
| 12/07/1993 | US5268467 Immunomodulatory polysaccharide fractions from Astragalus plants |
| 12/07/1993 | US5268462 Oleandomycin oximes |
| 12/07/1993 | US5268389 Containing a benzene ring |
| 12/07/1993 | US5268387 Containing ester or carbamate group |
| 12/07/1993 | US5268386 Certain 3,4-dihydro 4-oxospiro [2H-1 benzopyrans] useful for treating hyperuricemia |
| 12/07/1993 | US5268385 Tetralin structure containing amine groups |
| 12/07/1993 | US5268384 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
| 12/07/1993 | US5268382 Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus |
| 12/07/1993 | US5268377 Imidazoindolizine derivatives process for preparation thereof and use thereof to treat hypertension |
| 12/07/1993 | US5268376 Containing alkoxy substitution |
| 12/07/1993 | US5268375 Dinitrogen heterocyclic derivatives N-substituted by a biphenylmethyl group, and the pharmaceutical compositions in which they are present |
| 12/07/1993 | US5268368 Cyclophosphamide--amino acid lyophilizates |
| 12/07/1993 | US5268367 Composition and method for lowering blood level of LDL-cholesterol |
| 12/07/1993 | US5268366 Polysaccharide composition or polysaccharide having heparinoid activity, process for producing the same, and anticoagulant containing the same as active ingredient |
| 12/07/1993 | US5268364 Block addition of a serine or threonine residue to protein |
| 12/07/1993 | US5268361 Hydroxyazido derivatives and related compounds as renin inhibitors |
| 12/07/1993 | US5268181 Method of using niacin to control nocturnal cholesterol synthesis |
| 12/07/1993 | US5268176 Method and compositions for the non-invasive treatment of telangiectasia |
| 12/07/1993 | CA2095944A1 Azole derivatives and antimycotic and antiaromatase agents containing them |
| 12/07/1993 | CA2013799C N-alkenylbenzo(b) thieno-(3,2-b) oxazin-2,4-diones |
| 12/07/1993 | CA1338840E Compositions and Methods for Retarding the Effects of Aging of the Skin |
| 12/07/1993 | CA1325077C Beta-lactam derivatives |
| 12/07/1993 | CA1325013C Cyclopropanecarboxylate esters related to pyrethric acid; process for preparing the same and their use for the control of parasites |
| 12/07/1993 | CA1325011C Tetrahydronaphthalene and indane derivatives |
| 12/07/1993 | CA1325009C P-hydroxy phenone derivatives and the use thereof |
| 12/07/1993 | CA1325006C Steroid 5-alpha-reductase inhibitors |
| 12/07/1993 | CA1324961C Oral anesthetic composition containing dyclonine |
| 12/07/1993 | CA1324960C Procedure for obtaining the preparation for the treatment of the disease psoriasis drug for the treatment of psoriasis and its application |
| 12/07/1993 | CA1324959C Stabilized anthracycline preparation |
| 12/07/1993 | CA1324955C Synergistic antimicrobial composition |
| 12/06/1993 | EP0608217A4 Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition. |
| 12/06/1993 | CA2097779A1 New pyrrolothienopyrazinic compounds, process for their preparation and pharmaceutical composition containing them |
| 12/06/1993 | CA2097766A1 Pyridyl-1,2,5-oxadiazolecarboxamide-2-oxides |
| 12/06/1993 | CA2097731A1 Antitumoral compounds |
| 12/06/1993 | CA2097465A1 Pyrazinoindoles |